Session Details
[28P-pm]Genes and genetic information
Fri. Mar 28, 2025 1:30 PM - 5:00 PM JST
Fri. Mar 28, 2025 4:30 AM - 8:00 AM UTC
Fri. Mar 28, 2025 4:30 AM - 8:00 AM UTC
Poster (MARINE MESSE FUKUOKA Hall B: Exhibition Room [1F])
[28P-pm311]Effects of ADAR2 in Metabolic Dysfunction-Associated Steatohepatitis (MASH) progression
Tzu-Chi Hung1, ○Yun-Wen Chen1 (1. National Cheng Kung University)
[28P-pm312S]Effects of changes in charge distribution in phosphorylated Stm1 protein on liquid–liquid phase separation
○Suzuna Kuwahara1, Marin Kobashigawa1, Shinya Takazaki1 (1. Fac. of Pharm. Sci., Nagasaki Itn. Univ.)
[28P-pm313]uORF-mediated translational regulation in response to intracellular polyamine levels
○Kazuhiro Nishimura1,2, Kyoko Misawa1, Riku Morikawa1, Satsuki Isozaki1, Shiori Murata1, Shota Wakui1, Ayano Kanari1 (1. Sch. Pharm., IUHW, 2. Sch. Pharm. Narita, IUHW)
[28P-pm314S]Molecular functional analyses of immune checkpoint molecule, VSIR, in pancreatic cancer
○Yumika Nakano1, Mariko Kawachi1, Kiyoshi Yanagisawa1 (1. Faculty of Pharmacy, Meijo University)
[28P-pm315S]Functional analyses of immune checkpoint molecule, VSIR, in triple negative breast cancer
○Kanon Nagahama1, Mariko Kawachi1, Kiyoshi Yanagisawa1 (1. Faculty of Pharmacy, Meijo University)
[28P-pm316]The function of Werner helicase interacting protein 1 (WRNIP1) in translesion synthesis
○AKARI YOSHIMURA1, Takuya Abe1, Masayuki Seki1 (1. Fac. of Pharm. Sci., Tohoku Med. and Pharm. Univ.)
[28P-pm317]Analysis of drug responsiveness of human β4-galactosyltransfease 3 promoter region
○Takeshi Sato1, Atsushi Hitomi1, Riho Tange1 (1. Lab. of Glycobiol., Nagaoka Univ. of Technol.)
[28P-pm318]Interferon-dependent mechanism in positive-feedback regulation of STAT1 gene
○Katsutoshi Yuasa1, Aimi Masubuchi1, Tomo Okada1, Miho Shinya1, Yui Inomata1, Honoka Kida1, Sayoko Shyouji1, Hirona Ichikawa1, Tetsuyuki Takahashi1, Kiyoshi Mihara1, Masashi Muroi1, Takao Hijikata1 (1. Pharm., Musashino Univ.)
[28P-pm319]Analysis of mechanisms to overcome replication blockage in human cells
○Rie Kanao1,2, Chikahide Masutani1,2 (1. Res. Inst. Environ. Med., Nagoya Univ., 2. Nagoya Univ. Grad. Sch. Med.)
[28P-pm320]Identification of specific sub-populations of cells in recurrent glioblastoma by in silico analysis of single-cell RNA sequencing data.
○Hayato Aikoh1,2, Takahama Kazuhiro3, Suetsugu Kimitaka1,3, Terazono Hideyuki1,3 (1. Grad. Sch. Med., Kagoshima Univ., 2. Tarumizumh, 3. Kagoshima Univ. hosp.)
[28P-pm321S]Regulation of autism-associated SETD5 gene expression via histone methylation.
○Honoka Ashitomi1, Tadashi Nakagawa1,2, Shoko Sashiyama1,3, Toru Hosoi1 (1. Fac. Pharm. Sci., Sanyo-Onoda City Univ., 2. Grad. Sch. Med., Tohoku Univ., 3. Grad. Sch. Med., Kumamoto Univ.)
[28P-pm322S]Mechanism of primary cilia formation by developmental disorder-associated protein ANKRD11.
○Aki Shigenaka1, Tadashi Nakagawa1,2, Toru Hosoi1 (1. Fac. Pharm. Sci., Sanyo-Onoda City Univ., 2. Grad. Sch. Med., Tohoku Univ.)
[28P-pm323]Effects of Urate Transporter ABCG2 for Urinary Urate Elimination
○Yuki Ohashi1,2, Satoshi Yamaguchi3, Kimiyoshi Ichida1,4,5 (1. Tokyo University of Pharmacy and Life Sciences, 2. Nagoya University Graduate School of Medicine, 3. Kitasaito Hospital, 4. Jikei University School of Medicine, 5. Chiba Health Promotion Center, East Japan Railway Company)
[28P-pm324]The novel 3’-UTR variant of KANSL1 mRNA has a region complementary to tau mRNA and activates its translation.
○Toru Tanaka1, Sachiyo Ohashi1, Shunsuke Kobayashi1 (1. Coll. of Pharm., Nihon Univ.)
[28P-pm325S]Comprehensive evaluation of the effect of end-modified DNA donors on CRISPR knock-in
○Rioka Takagi1, Shoji Hata1, Chiharu Tei1, Akira Mabuchi1, Atsushi Toyoda2, Daiju Kitagawa1 (1. Grad. Sch. Pharm. Sci., Tokyo Univ., 2. NIG)
[28P-pm326S]The effects of MBNL1 and CTG repeat on the alternative splicing of Junctophilin3, the causal gene of Huntington’s disease-like 2
○Atsutaka Ishikawa1, Yoshitaka Aoki1, Motoaki Yanaizu1, Yoshihiro Kino1 (1. Sch. Pharm. Sci., Meiji Pharmaceutical University)
[28P-pm327]Regulation of the autism-related gene Setd5 by the KRAB/KAP complex
○Tadashi Nakagawa1,2, Toru Hosoi1 (1. Fac. Pharm. Sci., Sanyo-Onoda City Univ., 2. Grad. Sch. Med., Tohoku Univ.)
[28P-pm328S]Splicing analysis of CD33 using a full-length protein-coding minigene
○Rui Nakagawa1, Motoaki Yanaizu1, Yoshihiro Kino1 (1. Grab. Sch. Pharm. Sci., Meiji Phamaceutical Univ.)
[28P-pm329S]Comparative Analysis of PTK2B Isoforms
○Masahide Kato1, Ayaka Isazawa1, Motoaki Yanaizu1, Yoshihiro Kino1 (1. Grad. Sch. Pharm. Sci., Meiji Pharmaceutical Univ.)
[28P-pm330S]Investigation of the splicing regulatory factors for TYROBP, an adaptor protein of TREM2
○Hayato Suzuki1, Kurumi Tsuchida1, Motoaki Yanaizu1, Yoshihiro Kino1 (1. Meiji Parmaceutical Univ.)
[28P-pm331S]Global epigenomics approach with endothelium from down syndrome trisomy model
○Takuma Horikawa1, Shintaro Funasaki1, Takeshi Inagaki2, Chisen Takeuchi3, Takashi Minami1 (1. Institute of Resource Development and Analysis,Kumamoto Univ., 2. Institute for Molecular and Cellular Regulation,Gunma Univ., 3. The JIKEI university hospital)
[28P-pm332S]Characterization of ATXN1 as a splicing regulatory factor
○Ai Ohki1, Yoshitaka Aoki1, Masahide Kato1, Arisa Kubokawa1, Motoaki Yanaizu1, Yoshihiro Kino1 (1. Grad. Sch. Pharm. Sci., Meiji Pharmaceutical Univ.)
[28P-pm333S]Functional analysis of the primase-associated factor PAF in Kaposi's Sarcoma-Associated Herpesvirus
○Marina Takada1, Yuki Iwaisako1, Masahiro Fujimuro1 (1. kyoto pharm.univ.)
[28P-pm334]A novel regulatory mechanism for Polycomb repressive complexes (PRCs) : "PRC1-PRC2 complex model"
○Kazumasa Aoyama1, Kei Kikuchi1, Yuuki Tanaka1, So Taguchi1, Kousuke Higashi1, Yousuke Nakazawa1, Megumi Tago1 (1. Pharm. Keio Univ.)
[28P-pm335S]Exploration of therapeutic strategies targeting “retained H3K27me3” for EZH2-deficient MDS
○Yuuki Tanaka1, Kazumasa Aoyama1, Kei Kikuchi1, So Taguchi1, Kousuke Higashi1, Yousuke Nakazawa1, Megumi Tago1 (1. Pharm. Keio Univ.)